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Objectives: We hypothesized that high-molecular-weight (MW) cross-linked (CL) hyaluronic acid (HA)
improves joint lubrication and has an enhanced chondroprotective effect. We examined the histopath-
ological changes and friction coefﬁcients in osteoarthritic knee joints after injecting high-MW CL HA.
Design: A bilateral anterior cruciate ligament transection (ACLT) model in 20 Japanese white rabbits was
used. From week 5 after transection, low-MW HA (0.8  106 Da; HA80) or high-MW CL HA (6  106 Da;
HA600) was injected weekly into 10 right knee for 3 weeks; normal saline (NS) was injected into the 10
left knee. A sham operation was undertaken to exclude spontaneous osteoarthritis (OA) in ﬁve knees.
Results were evaluated with macroscopy, histopathology (Kikuchi’s score), biomechanical testing, and
rheological assessment of the joint ﬂuid viscoelasticity. Statistical analysis was performed using one-way
analysis of variance with a 95% conﬁdence interval (CI) (P < 0.05).
Results: The macroscopic ﬁndings showed severely damaged cartilage in 30% of the NS group and 20% of
the HA80 and HA600 groups and intact cartilage in 100% of the sham group. The histological scores and
friction coefﬁcients of the HA600 group were signiﬁcantly lower than those of the NS group (P ¼ 0.007
and P ¼ 0.002, respectively). Viscoelasticity measurements of the joint ﬂuid showed no signiﬁcant dif-
ferences between the three treatment groups.
Conclusion: High-MW CL HA exerts potential chondroprotective effects and produces superior friction
coefﬁcients. Our results suggest that HA600 delays the progression of OA effectively and improves joint
lubrication signiﬁcantly.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Current treatments for osteoarthritis (OA) range from minimal
nonsurgical measures to invasive and surgical modalities. Nonsur-
gical nonpharmacological measures include exercise, weight loss,
and bracing; surgical measures vary from arthroscopic debride-
ment and osteotomy to arthroplasty. Pharmacological therapies,
such as analgesics, intra-articular injections, and topical treat-
ments, mainly target the palliation of pain1,2. Chondroprotective
agents are deﬁned as compounds that (1) stimulate the synthesis ofT. Funakoshi, Department of
okkaido University, Kita 15,
-706-5937; Fax: 81-11-706-
sy), tfunakoshi@gmail.com,
0@gmail.com (F. Sasazawa),
.hokudai.ac.jp (S. Tadano),
s Research Society International. Pcollagen and proteoglycans by chondrocytes and production of
hyaluronic acid (HA) by synoviocytes; (2) inhibit cartilage degra-
dation; and (3) prevent ﬁbrin formation in the subchondral and
synovial vasculature3. Compounds that show some of these char-
acteristics are endogenous molecules of the articular cartilage,
including HA, glucosamine, and chondroitin sulfate.
Viscosupplementation is an intra-articular therapeutic modality
based on the physiological importance of HA in the synovial
joints4,5. HA is a heteropolysaccharide formed by a variable number
of repeating units of D-glucuronic acid and N-acetylglucosamine. It
is formed by synoviocytes, ﬁbroblasts, and chondrocytes inside
joints and is present in the synovial ﬂuid and the extracellular
matrix of the cartilage. HA is crucial to the viscoelastic properties
that allow the efﬁcient movement of articular joints6e9.
Several HA preparations are being marketed with varying
molecular weights (MWs), ranging from 0.5  106 Da to
6  106 Da. Clinical trials have not indicated a clear advantage of
one product over another10. One of the goals of HA therapy is to
restore the viscoelasticity of the synovial ﬂuid and the naturalublished by Elsevier Ltd. All rights reserved.
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in a healthy knee joint is 6  106 Da. It has been reported that the
MW of HA in a human arthritic knee joint decreases to 0.5e
3  106 Da11. HA can potentially improve viscoelasticity, and a
higher MW of HA is thought to improve the viscoelastic properties
of HA preparations. However, the effects of high-MW cross-linked
(CL) HA on joint viscoelasticity and joint lubrication have not yet
been reported.
We hypothesized that high-MW CL HA improves joint lubrica-
tion and has an enhanced chondroprotective effect compared with
lower-MW HA. We examined the histopathological changes in
osteoarthritic knee joints after HA injection and investigated the
relationship between the friction coefﬁcient and the MW of HA.
Materials and methods
OA model
Twenty-three female Japanese white rabbits aged 12 weeks and
weighing 2.6e2.9 kg were purchased from a professional breeding
company (Japan SLC Inc., Hamamatsu, Japan) and used for this
experiment. Our institutional Animal Care Committee approved the
study, which was conducted according to its ethical guidelines and
regulations. All animals were anesthetized with an intravenous
injection of 0.05 mg/kg phenobarbital sodium, followed by gas
anesthesia with isoﬂurane. Both knees of each rabbit were shaved,
prepared, and draped in a sterile environment. To generate osteo-
arthritic joints, anterior cruciate ligament transection (ACLT) was
performed in both knees using a medial parapatellar approach.
After the patella was dislocated laterally, the knee was ﬂexed
maximally so that the anterior cruciate ligament could be readily
visualized and identiﬁed. It was then transected with a #11 blade.
The knee joints were inspected for bleeding and washed thor-
oughly with sterile normal saline (NS). The joint capsule was closed
with a running suture of 4-0 nylon, and the skin incisionwas closed
with running mattress sutures of 3-0 nylon12. Instability was
conﬁrmed in all knees with positive anterior drawer and Lachman
tests. After surgery, the animals were allowed unrestrained cage
activities while they were monitored for infections and other
complications. To rule out the development of spontaneous OA, a
bilateral arthrotomy without the ACLT was performed as a sham
non-OA model.
Injection materials
In this study, we used two HA preparations of different MWs:
HA80 (Artz Dispo, Seikagaku Corp., Tokyo, Japan), with an average
MWof 0.8 106 Da; and HA600 (Hylan G-F 20, Synvisc, Genzyme,
a Sanoﬁ company, Cambridge, MA), with an average MW of
6  106 Da. Both are available for patient use as a medical device
loaded with sterile injection material. We used NS (0.9%) as the
control.
Treatment regimens
In postoperative week 5, 46 knees from 23 rabbits were injected
with NS or HA (HA80 or HA600). NS was injected into the left knees
and HA (HA80 or HA600) was injected into the right knees. The
sham group (six knees from three rabbits) received bilateral NS
injections. The intra-articular injection of 0.3 mL of each material
was performed under intravenous anesthesia induced with
0.05 mg/kg phenobarbital sodium using a 26-gauge syringe under
sterile conditions. Three weekly injections were administered, and
all animals were killed 8 weeks after surgery (1 week after the third
injection) with an intravenous lethal dose of phenobarbital sodium.From the OAmodel, 30 knees were randomly assigned to one of the
three treatment groups (10 per group) with NS, HA80, or HA600.
From the sham group, ﬁve knees were collected randomly from a
total of six knees for evaluation.Macroscopic evaluation
Macroscopic assessment of the knees (ﬁve knees per group) was
performed in all four compartments of every knee: medial femoral
condyle, lateral femoral condyle, medial tibial plateau, and lateral
tibial plateau. A solution of India ink diluted with phosphate-
buffered saline (1:5) was used to stain the articular cartilage, and
the stained specimens were photographed using a high-resolution
digital camera. The ﬁndings were evaluated according to the
following classiﬁcation: Grade 1 (intact surface), surface was
normal in appearance and did not retain India ink; Grade 2 (min-
imal ﬁbrillation), surface retained India ink as elongated specks or
light-gray patches; Grade 3 (overt ﬁbrillation), areas were velvety
in appearance and retained India ink as intense black patches; and
Grade 4 (erosion), loss of cartilage exposing the underlying bone.
Grade 4 was divided further into the following three subgrades:
Grade 4a, erosion <2 mm; Grade 4b, erosion 2 mm and <5 mm;
and Grade 4c, erosion 5 mm13.Histopathological evaluation
The distal femur and proximal tibia from each knee (ﬁve knees
per group) were ﬁxed with 4% phosphate-buffered para-
formaldehyde for 24 h, decalciﬁed with 10% ethylenediaminetetra-
acetic acid (pH 7.4) for 10 days, and then embedded in parafﬁn. A
5 mm thick sagittal section was cut from the center of each medial
femoral condyle. The sections were stained with Safranin-O. The
slideswere coded beforemicroscopic examination and evaluated by
threeobservers.Degenerative changes to thearticular cartilagewere
assessed quantitatively using the scoring system described by
Kikuchi et al. (Table I)14.Friction test
Fifteen knees from the OAmodel were used for this test (ﬁve per
group), and these specimens were used exclusively for this test. The
effects of the intra-articular injection of the test substances on joint
lubrication were assessed using a pendulum friction tester
designed by our laboratory for small samples [Fig. 1]. The knees
were resected at the proximal end of the femoral shaft and at the
distal end of the tibia and then secured to polyethylene tubes with
bone cement. All soft tissues were removed from the joint except
the joint capsule and the tendons and ligaments around the knee.
The distal end of the tibia of each sample joint was attached to the
base plate, and the femoral shaft was attached to the pendulum.
The pendulum motion was calculated from two translational dis-
placements by laser displacement sensors (LK-G30, Keyence, Tokyo,
Japan), and the angular displacement was calculated by an accel-
erometer that detected the direction of gravity (100 Hz) (WAA-006,
Wireless Technologies, Inc., Tokyo, Japan). The total weight of the
pendulum, including its frame, was 40 N in normal sea-level
gravity. During the experiments, the joints were kept moist with
injections of NS. Based on the linear damping oscillation curve of
the pendulum, the frictional coefﬁcient m was calculated using the
following equation: m ¼ LDq/4r, where r is the radius of the rabbit
femoral condyle, L is the distance between the pendulum’s center
of gravity and center of rotation, and Dq is the average decrease in
the amplitude of the pendulum swing per cycle.
Table I
Histopathological scores for the evaluation of cartilage degeneration13
Category þ1 þ2 þ3 þ4
Loss of superﬁcial layer <Slight Moderate Focally severe Extensively severe
Erosion of cartilage <Detectable Moderate Focally severe Extensively severe
Fibrillation and/or ﬁssures <Noticeable
(<1 very small)
Moderate (1 small) Marked (2 small or 1 medium) Extensive (3 small, 2 medium,
or 1 large)
Loss of proteoglycans <Paler stain than
control
Moderate loss of Safranin-O
stain
Marked loss of Safranin-O stain Total loss of Safranin-O stain
Disorganization of
chondrocytes
Noticeable Moderate, with some loss
of columns
Marked loss of columns No recognizable organization
Loss of chondrocytes <Noticeable reduction
in cells
Moderate reduction in cells Marked reduction in cells Very extensive reduction in cells
Exposure of subchondral
bone
<Focal exposure of bone Moderate exposure of bone Fairly extensive exposure of
bone
Very extensive exposure of bone
Cluster formation <3e4 small or 1e2
medium
5e6 small, 3e4 medium,
or 1e2 large
7 or more medium or 5e6 large 7 or more small, 5e6 medium,
or 3e4 large
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After the animals were killed, the joint ﬂuid was aspirated and
collected. The samples were centrifuged and stored without pre-
servatives at 80C. Before testing, the samples were thawed to
room temperature. The viscoelastic properties of the joint ﬂuids
were measured using a dynamic mechanical analyzer (DMA)
(Rheosol-G3000NT, UBM Co. Ltd, Huga, Japan). The rheological
properties of the synovial ﬂuids were evaluated at a controlled
temperature of 25  1C. The DMA has two plates, one parallel and
one cone-shaped, and the sample was placed between them. The
synovial ﬂuid material was subjected to sinusoidal shear forces
(strain, stress), and the output signals were recorded. The rheologyFig. 1. Illustration of the pendulum friction tester used in this study. The friction co-
efﬁcient m was calculated using the equation m ¼ LDq/4r, where r is the radius of the
rabbit femoral condyle, L is the distance between the pendulum’s center of gravity and
center of rotation, and Dq is the average decrease in the amplitude of the pendulum
swing per cycle.of the synovial ﬂuid samples was investigated by measuring the
steady-state viscosity and small-amplitude oscillatory movements.
The small-amplitude oscillatory shear experiments allow the
measurement of the unsteady response of a sample and hence the
determination of its linear viscoelastic properties15,16. The data
collected from the DMA are analyzed to yield the shear storage
modulus (G0), which gives information about the ﬂuid’s elastic
character and is related to the energy stored in the ﬂuid during
deformation, and the shear loss modulus (G00), which describes the
ﬂuid’s viscous character and is related to the energy dissipated as
heat during ﬂow. The viscoelastic properties of the synovial ﬂuid
samples were assessed with a sweeping oscillatory frequency that
included the physiological frequencies of knee movement, ranging
from 0.01 Hz and 0.1 Hz (slower knee movements, such as occur
while at rest and walking, respectively) to 3e4 Hz (more rapid knee
movements, such as occur during running).
Statistical analysis
The data are presented as mean  standard deviation (SD). Data
were considered independently with the assumption of a Gaussian
distribution. The statistical analysis of all data was performed using
one-way analysis of variance followed by Tukey’s post-hoc test
with conﬁdence intervals (CIs) of 95%. P-values less than 0.05 were
considered signiﬁcant. All analyses were performed using Graph-
Pad Prism (GraphPad Software, Inc., San Diego, CA).
Results
Perioperative conditions
All operations were performed smoothly without complica-
tions, such as joint sepsis or contractures. When the animals were
killed, there was no signiﬁcant variation in the body weights of the
experimental groups, and the complete transection of all anterior
cruciate ligaments was conﬁrmed grossly. The joint ﬂuid samples
were generally clear or slightly blood tinged, with no gross signs of
inﬂammation or infection; their volumes were in the range of 200e
400 mL for samples from HA-injected knees and approximately
100 mL for samples from saline-injected knees.
Gross pathology
Using India ink and a previously described grading system13, all
knees were stained and graded at week 8 after ACLT. All stained
knees showed some degree of degenerative changes, ranging from
mild to severe, which were, in some cases, accompanied by joint
Fig. 2. Macroscopic assessment of the medial femoral condyles from each group 8
weeks after surgery. Cartilage degeneration in the HA600 group was generally less
severe than that in either the NS or HA80 group (n ¼ 5 per group).
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changes than the tibial plateaus, which tended to show mild
changes. All the samples from the sham groupwere Grade 1. For the
OA model, the NS and HA80 groups showed fairly extensive
changes, mainly at the medial femoral condyle, whereas the HA600
group showed milder degeneration. Mild changes (Grade 2: mini-
mal ﬁbrillation) were found in 10% of the NS group, 20% of the HA80
group, and 40% of the HA600 group, whereas severe changes
(Grade 4b: erosion 2 mm and <5 mm) were found in 30% of theFig. 3. Histological ﬁndings (Safranin-O stain) of the medial femoral condyles from each gro
that had not been operated on (H, J).NS group and 20% of the HA80 and HA600 groups and no samples
of Grade 4c were detected [Fig. 2].Histopathology
Microscopic examination of the articular cartilage showed
varying degrees of degenerative change in all the knees from the
three groups. The severe changes, such as the loss of the superﬁcial
layer, ﬁbrillation/ﬁssures, and the loss of Safranin-O staining, were
observed in the NS and HA80 groups [Fig. 3(A) and (B)], whereas
samples from the HA600 exhibited less severe changes [Fig. 3(C)].
In the HA80 group, there was a moderate reduction in the severity
of cartilage degeneration, whereas in the HA600 group, there was a
clear andmarked reduction in the severity of the lesions. The loss of
Safranin-O staining at the medial femoral condyle was also milder
in the HA600 group than in the HA80 group. The overall scores for
the HA600 group were signiﬁcantly lower than those for the NS
group (P ¼ 0.007). The sham group showed signiﬁcantly better
overall scores compared with the NS (P < 0.0001), the HA80
(P< 0.0001), and the HA600 groups (P¼ 0.0009). The HA600 group
also showed signiﬁcantly better scores for the loss of the superﬁcial
layer and the loss of proteoglycans, whereas only the loss of the
superﬁcial layer was signiﬁcantly better when the HA600 group
was compared with the HA80 group (P ¼ 0.004). The sham group
exhibited better scores for most of the scoring system categoriesup 8 weeks after surgery. NS (A, D); HA80 (B, E); HA600 (C, F); sham (G, I); normal knee
Table II
Mean histopathological scores for the medial femoral condyles in each group 8 weeks after anterior cruciate ligament transaction
Category Sham (n ¼ 5) NS (n ¼ 5) HA80 (n ¼ 5) HA600 (n ¼ 5)
Loss of superﬁcial layer 1.13  0.18*,x 2.53  0.38 2.6  0.43 1.53  0.56a,b
Erosion of cartilage 1.2  0.18*,x 2.47  0.45 2.4  0.55 1.8  0.61
Fibrillation and/or ﬁssures 1.07  0.15*,x 2.4  0.72 2.33  0.62 2  0.71
Loss of proteoglycans 1.2  0.18*,x,{ 2.67  0.33 2.27  0.43 1.93  0.36c
Disorganization of chondrocytes 1.47  0.18*,x,{ 3.13  0.29 2.23  0.43e 2.47  0.45d
Loss of chondrocytes 1.07  0.15*,x 2.87  0.61 2.47  0.87 2.07  0.28
Exposure of subchondral bone 1  0.0x 1.2  0.18 1.8  0.65 1.2  0.45
Cluster formation 1.2  0.18*,x,{ 2.86  0.38 2.13  0.56 2.33  0.53
Sum 9.33  0.24B,# 20.13  1.28 18.272.28 15.33  2.9e
Mean  SD.
*,x,{P< 0.05 vs NS, HA80, and HA600, respectively;BP< 0.0001 vs NS, and HA80; #P¼ 0.0009 vs HA600; aP¼ 0.012 vs NS; bP¼ 0.004 vs HA80; cP¼ 0.018 vs NS; dP¼ 0.04 vs NS;
and eP ¼ 0.007 vs NS.
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overall scores for the HA600 group tended to be lower than those
for the HA80 group, there was no statistically signiﬁcant difference
between the two groups. This was also true when the NS and HA80
groups were compared, and although the HA80 scores tended to be
lower than those of the NS group, the differences were not statis-
tically signiﬁcant. The histological scores (8 ¼ normal to 32 ¼ the
severest OA) for the medial femoral condyle are shown in Table II.
Friction test
Knees in the OA model, were tested biomechanically to evaluate
the friction coefﬁcients. The friction coefﬁcients were measured
using the previously described systemwhile the knees were under
60 ﬂexion. The mean friction coefﬁcient of the HA600 group was
signiﬁcantly lower than that of the NS group (P ¼ 0.002), whereas
there was no signiﬁcant difference between the NS and HA80
groups or between the HA80 and HA600 groups, although the
values found for the HA600 group tended to be lower than those for
the HA80 group [Fig. 4].
Dynamic mechanical analysis
Using the previously described apparatus, the rheological
properties of the synovial ﬂuid samples from the three groups (NS,
HA80, and HA600) were recorded. Neither the G0 nor the G00 mea-
surements differed signiﬁcantly between the three groups
(Table III).Fig. 4. Mean values for the friction coefﬁcients obtained with the pendulum friction
test. Error bars represent the 95% CIs (n ¼ 5 per group). *P ¼ 0.002 of HA600 vs the NS
control.Discussion
We examined the chondroprotective effects of high-MW CL HA
on knee OA induced with ACLT in rabbits. This OA model showed
obvious degenerative changes in the articular cartilage 8 weeks
after surgery, which resembled those observed in humans. The
sham group did not show degenerative changes, thus excluding the
possibility of spontaneous OA. Histological analysis showed that
the intra-articular injection of HA inhibited OA progression signif-
icantly. Within the three treatment groups, less OA progression and
better friction coefﬁcients were seen in the HA600 group than in
the HA80 and NS groups. These results indicate that intra-articular
injections of HA600 have a chondroprotective effect on the articular
cartilage.
A number of articles have investigated the effects of different
MWs of HA14,17e20. Kikuchi et al. demonstrated that the injection of
low-MW HA (0.8  106 Da) did not signiﬁcantly reduce OA pro-
gression compared with NS injection14; other reports from Kawano
et al. and Igarashi et al. showed similar results17,18. Our histopath-
ological results are consistent with those reports. On the other
hand, data from Shimizu et al. showed that low-MWHA exhibited a
cartilage-protective effect equal to that of high-MWCL HA20. In our
bilateral ACLT model, OA progression is expected to differ from that
in their unilateral model, and the different number of injections,
especially for low-MW HA, may affect the outcome. Recent litera-
ture reported a new highly CL HA (Varioﬁll, ADODERM GmbH,
Langenfeld, Germany), and the results suggested a better pain relief
effect compared with Synvisc21,22. However, we have no data on
the analgesic effects of these materials. Future study is needed to
investigate the effects of different types of high-MW CL HA.
In the histological analysis, the HA600 group had lower scores
for the losses of the superﬁcial layer, proteoglycans, and chon-
drocytes. Biomechanical testing showed that HA600 yielded
signiﬁcantly lower friction coefﬁcients in the ACLT knees than did
saline injections. Therefore, based on the friction test results, we
consider high-MW CL HA to act as a chondroprotective factor. A
previous article reported that the superﬁcial zone of the articular
cartilage does not have special properties that enhance its frictional
response23. In contrast, several investigators have shown that
lubricin (a superﬁcial zone protein, also called proteoglycan 4),
which is present both in the superﬁcial layer of the articular
cartilage and in the synovial ﬂuid, is very important in joint
biomechanics and boundary lubrication24,25. Another recent report
also showed that supplementation with proteoglycan 4 can restore
normal cartilage boundary lubrication to osteoarthritic synovial
ﬂuid26. Although we did not investigate the lubricin in the cartilage
immunohistochemically, our histological ﬁndings show clearly the
lack of a superﬁcial zone on the surface of the cartilage in all
experimental groups, except the normal knee cartilage. The great-
est histological difference between the three groups was in the
Table III
Viscoelasticity of normal joint ﬂuid samples from each group compared with the viscoelasticity of the injected HA preparation measured at different frequencies (Hz)
G0 (Pa) (n ¼ 5) G00 (Pa) (n ¼ 5)
0.01 Hz 0.1 Hz 1 Hz 4 Hz 0.01 Hz 0.1 Hz 1 Hz 4 Hz
NS 0.05  0.03 0.1  0.07 0.2  0.13 0.26  0.18 0.06  0.04 0.11  0.07 0.15  0.08 0.19  0.08
HA80 0.02  0.02 0.05  0.03 0.14  0.07 0.23  0.15 0.04  0.03 0.1  0.08 0.2  0.17 0.24  0.26
HA600 0.05  0.01 0.1  0.03 0.15  0.06 0.24  0.13 0.07  0.03 0.14  0.06 0.2  0.09 0.25  0.13
Means  SD (n ¼ 5). G0 ¼ shear storage modulus (measuring the ﬂuid’s elastic character); G00 ¼ shear loss modulus (measuring the ﬂuid’s viscous character); Hz ¼ Hertz;
Pa ¼ Pascal.
S. Elmorsy et al. / Osteoarthritis and Cartilage 22 (2014) 121e127126uppermost layer of the cartilage. In the present study, we deﬁned
the uppermostw100 mm as the superﬁcial layer. We found that the
cellular abundance and cellular shape in the uppermost layer in the
HA600 group were similar to those in normal unoperated knees,
whereas the superﬁcial layer was almost acellular, with no pro-
teoglycans, in the NS and HA80 groups. Seror et al. reported that the
aggrecan-HA layer is a much better boundary lubricant than HA
alone27, and HA supplementation is also suggested to suppress
proteoglycan loss28. Of interest, a previous in vitro study demon-
strated that changes in the MW of HA can affect synovial ﬂuid’s
cartilage boundary lubricating ability in combination with the
physiological levels of proteoglycan 429. A more recent study
showed that high-MW CL HA can improve the cartilage integrity
and might also stimulate cartilage repair by increasing collagen II
and inhibiting interleukin-1b-mediated matrix degradation by
reducing matrix metalloproteinases30. These data support our
histological ﬁnding that HA600 preserved the superﬁcial layer and
improved the proteoglycan content.
Synovial joint lubrication involves two elements: ﬂuid lubrica-
tion and boundary lubrication31,32. The viscoelastic behavior of
high-MW CL HA may affect the ﬂuid lubrication in the knee joint.
The elasticity and viscosity of High-MW CL HA are signiﬁcantly
greater than those of low-MW HA under in vitro conditions. How-
ever, in our study, measurements of the viscoelasticity of the joint
ﬂuid 1 week after the last injection showed no signiﬁcant differ-
ences between the three experimental groups. We consider
boundary lubrication to be the main component of the lubrication
afforded by our test samples of HA600. The longitudinal rheological
evaluation of the joint ﬂuid was limited because the volume of the
ﬂuid was small in this rabbit OA model. Changes in the viscoelastic
properties of HA and its MW after injection should be clariﬁed in a
future study.
This study had several limitations. First, although we are
conﬁdent that the control injection of NS had little effect on joint
lubrication, saline might slightly affect joint lubrication and the
rheological characteristics of the synovial ﬂuid. Further, although
we repeated the in vitro rheological tests on joint ﬂuids at 25C and
37C and found no signiﬁcant differences (data not shown), we
conducted no in vivo evaluations, which limit the generalizability of
our ﬁndings. Second, we could not evaluate any changes in the MW
of high-MW CL HA in vivo because the molecules are very large,
making their exact measurement unfeasible. Third, we examined
the viscoelasticity measurements at only one time point: 1 week
after the third injection. We suspect that measurements should be
made at earlier time points to clarify the evolution of differences in
viscoelasticity produced by the different injectionmaterials. Finally,
the small sample size and the skeletal immaturity of the animal
model are also limitation in the current study.
In summary, our ﬁndings show that the intra-articular injection
of high-MW CL HA is potentially chondroprotective, improving
joint lubrication in OA knees induced with ACLT. These attributes
should contribute to the retardation of OA progression and conse-
quently modify the pathological processes of OA. This evidence
should be useful when selecting HA preparations for intra-articular
injection procedures.Author contributions
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